Is Clonal Hematopoiesis a New Cardiovascular Risk Factor? Check back later for a possible video summary. Videos are created for most articles. Abstract This paper explores growing evidence that links clonal hematopoiesis, particularly clonal hematopoiesis of indeterminate potential (CHIP), to an increased risk of
Hematology
New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence
New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence Please like and subscribe if you enjoyed this video :-) Introduction Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, remains one of the most common and life-threatening complications in patients with cancer.
JAK2, CALR, and MPL Mutations: Advanced Treatment Strategies That Work
AI Blood Cancer Detection: 92% Accuracy in New Clinical Study
From COVID to Cancer: Understanding Hypercoagulability in Modern Practice – How Coagulopathies Evolved During the Pandemic
The Mystery of the Low Platelet Count: When is it ITP, and When is it Not? – Diagnostic pearls and Red flags for Thrombocytopenia
When Blood Clots Strike Young: What Every Doctor Should Know About VTE in Millennials – Unusual Thrombotic Presentations and Risk Factors
Gene Therapy Breakthrough: New Evidence Shows Promise for Hemophilia Cure
The Iron Truth: Are We Missing the Signs of Iron Overload? A Review of Hemochromatosis and Underdiagnosis in Practice
Hidden First Signs of Leukemia That Doctors Often Miss in Primary Care
